Titelia

Funds holding CUE BIOPHARMA INC

ISIN US22978P1066 · United States · LEI 549300PBW78KZA33WC97

Fund holders
7
Of which ETFs
1 6 other funds
Value held
750.1K $
Share of capital
42.9 % of 7.3M shares on Aug 12, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 1,520,020349.5K $20.92 %as of Mar 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 937,432215.5K $0.00 %12.90 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 385,453108K $0.00 %5.31 %as of Feb 28, 2026
Fidelity Total Market Index Fund Fidelity Concord Street Trust 139,86039.2K $1.93 %as of Feb 28, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 105,96629.7K $1.46 %as of Feb 28, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 29,2508.2K $0.40 %as of Feb 28, 2026
Avantis Total Equity Markets ETF American Century ETF Trust 32490.8 $0.00 %as of Feb 28, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.

FundWeight in fund
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026

Quarter after quarter

Each SEC quarterly data set, newest first. The change is read against the quarter before it.

QuarterHoldersChangeSharesChange
2026Q27+13,118,305-0.1 %
2026Q16-13,121,466-1.2 %
2025Q4703,159,788-15.9 %
2025Q37-23,757,214+25.7 %
2025Q29-12,990,066+14.0 %
2025Q110-32,623,323+0.5 %
2024Q413-462,609,631-38.4 %
2024Q359-234,238,800-16.0 %
2024Q282-25,047,740-1.6 %
2024Q184-35,128,842+3.6 %
2023Q4874,949,972

Institutional managers

50 managers declare this company to the SEC (Form 13F); the 25 largest follow.

ManagerSharesValue
Bleichroeder LP6,819,1641.6M $as of Mar 31, 2026
GC Wealth Management RIA, LLC4,631,6441.1M $as of Mar 31, 2026
Lion Point Capital, LP2,202,854506.4K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC1,064,690244.8K $as of Mar 31, 2026
Robertson Stephens Wealth Management, LLC478,500110K $as of Mar 31, 2026
BlackRock, Inc.449,161103.3K $as of Mar 31, 2026
Texas Capital Bank Wealth Management Services Inc397,42191.4K $as of Mar 31, 2026
ANGELES WEALTH MANAGEMENT, LLC310,00071.3K $as of Mar 31, 2026
ADVISORY RESEARCH INC257,22559.1K $as of Mar 31, 2026
STIFEL FINANCIAL CORP246,55656.7K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC213,82849.2K $as of Mar 31, 2026
BANK OF AMERICA CORP /DE/207,70847.6K $as of Mar 31, 2026
STATE STREET CORP179,35341.2K $as of Mar 31, 2026
DIADEMA PARTNERS LP131,99730.3K $as of Mar 31, 2026
NORTHERN TRUST CORP94,60621.8K $as of Mar 31, 2026
UBS Group AG88,35020.3K $as of Mar 31, 2026
Chicago Partners Investment Group LLC85,93749.9K $as of Mar 31, 2026
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO79,50018.3K $as of Mar 31, 2026
ADVISORTRUST PARTNERS, LLC50,00011.5K $as of Mar 31, 2026
Virtu Financial LLC49,55311 $as of Mar 31, 2026
Sigma Planning Corp38,7508.9K $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC34,1517.9K $as of Mar 31, 2026
Persistent Asset Partners Ltd33,3697.7K $as of Mar 31, 2026
Visionary Wealth Advisors29,2856.7K $as of Mar 31, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP24,6145.7K $as of Mar 31, 2026
Cite this page

Titelia. "Funds holding CUE BIOPHARMA INC". https://titelia.com/en/stocks/cue-biopharma-inc-US22978P1066